MEA Smoking Cessation Nicotine De-Addiction Companies

Pfizer (US) Expanded access to their Champix® (varenicline) medication for smoking cessation in several Middle Eastern countries through partnerships with local distributors.Conducted awareness campaigns about smoking-related health risks and the benefits of quitting, targeting specific demographics within the region.

GlaxoSmithKline (UK):Launched their Zyban® (bupropion) smoking cessation medication in select African countries with high smoking prevalence.Partnered with NGOs and healthcare organizations to integrate smoking cessation counseling into existing public health programs.

GSK Consumer Healthcare (UK) Increased marketing efforts for their Nicorette® nicotine replacement therapy (NRT) products in the region, targeting both traditional and digital platforms.Introduced new Nicorette® product variations based on local preferences and cultural sensitivities.

Quit Genius (UK) Partnered with a major telecom operator in the Middle East to offer their AI-powered smoking cessation app through mobile data plans at discounted rates.Developed customized app features and content addressing cultural nuances and religious considerations related to smoking in the region.

QuitSure (Egypt) Expanded their telehealth platform for smoking cessation counseling and support to cover additional countries in Africa.Offered culturally adapted counseling sessions and support groups delivered by local mental health professionals.

Go Smoke-Free (South Africa) Launched a gamified mobile app for smoking cessation targeting young adults in South Africa, incorporating local slang and social rewards.

List of MEA Smoking Cessation And Nicotine De-Addiction Key Companies in the Market

• Pfizer Inc


• VMR Products LLC


• Johnson & Johnson


• Novartis International AG


• Cipla Inc.


• GlaxoSmithKline plc.


• Nicotek LLC.


• Lorillard Inc